Articles From: National Instruments Declares Quarterly Dividend to Chicopee Bancorp, Inc. Reports First Quarter Results and Announces Quarterly Cash Dividend of $0.05 Per Share


2013/4/25
AUSTIN, Texas , April 25, 2013 /PRNewswire/ -- The National Instruments (Nasdaq: NATI) Board of Directors announced a quarterly dividend of $0.14 per share on the company's common stock.
Sign-up for National Instruments Declares Quarterly Dividend investment picks
2013/4/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010851&ProfileId=051205&sourceType=1 NORTHBROOK, IL --
Sign-up for Nanosphere Welcomes Ken Bahk, Ph.D. as Chief Strategy Officer and Announces Other Organizational Changes investment picks
2013/4/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010485&ProfileId=051205&sourceType=1 PETALUMA, CA --
Sign-up for Calix Reports First Quarter 2013 Financial Results investment picks
2013/4/25
http://media.marketwire.com/attachments/201103/22940_CalAmp_Logo_MW_735148.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010949&ProfileId=051205&sourceType=1 OXNARD, CA --
Sign-up for CalAmp Reports Fiscal 2013 Fourth Quarter and Full Year Results investment picks
2013/4/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010972&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Resource Capital Corp. Announces Full Exercise of Option to Purchase Additional Shares of Common Stock investment picks
2013/4/25
Derma Sciences, Inc. (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announces that patient screening has begun in the second of two Phase 3 clinical trials with the investigational topical drug candidate DSC127 for the treatment of diabetic foot ulcers.
Sign-up for Derma Sciences Begins Screening Patients in Second Phase 3 Trial with DSC127 for Healing Diabetic Foot Ulcers investment picks
2013/4/25
NEW YORK , April 25, 2013 /PRNewswire/ -- - RAISES 2013 GUIDANCE - - EBITDA GUIDANCE INCREASED FROM $132-135 MILLION TO $142-146 MILLION , IMPLYING YEAR OVER YEAR GROWTH OF +20% TO +23%   FIRST QUARTER HIGHLIGHTS:    Revenue increased from $235.2 million to $267.0 million , an increase of 13.6% Organic revenue increased 10.1% EBITDA increased from $8.4 million to $30.4 million , an increase of  262.7% EBITDA margin increased 780 basis points from 3.6% to 11.4%, an increase of 217% Free Cash Flow increased $22.0 million from an outflow of ($7.1) million to positive $14.9 million Debt refinancing materially reduces cost of capital and cash interest expense moving forward MDC Partners Inc. ("MDC Partners" or the "Company") today announced financial results for the three months ended March 31 , 2013.
Sign-up for MDC Partners Inc. Reports Record Results for the Three Months Ended March 31, 2013 investment picks
2013/4/25
NEW YORK , April 25, 2013 /PRNewswire/ -- MDC Partners Inc. ("MDC Partners" or the "Company") today announced that its Board of Directors has declared a cash dividend of $0.28 per share on all of its outstanding Class A shares and Class B shares.
Sign-up for MDC Partners Announces $0.28 Per Share Cash Dividend investment picks
2013/4/25
OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 Canada NewsWire To access the webcast, log on to the Investor Relations page of the OncoGenex website at www.oncogenex.com .
Sign-up for OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 investment picks
2013/4/25
BOTHELL, WA and VANCOUVER, BC , April 25, 2013 /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company's first quarter 2013 financial results will be released on Thursday, May 2, 2013 , and that the Company will host a conference call and live webcast at 4:30 p.m. ET that afternoon.
Sign-up for OncoGenex to Webcast Discussion of Clinical Development Program and First Quarter 2013 Financial Results on May 2, 2013 investment picks
2013/4/25
Urologix ® , Inc. (Nasdaq: ULGX) will host a conference call to present fiscal year 2013 third quarter results on Wednesday, May 1, 2013 at 4:00 p.m. CT, following the Company’s post-market press release on the same day.
Sign-up for Urologix to Host Its Fiscal Year 2013 Third Quarter Conference Call investment picks
2013/4/25
Q1 2013 Highlights - Record first quarter revenue of $286 million, up 10 percent year-over-year - Record orders for a first quarter in LabVIEW, PXI, CompactRIO and NI CompactDAQ products - GAAP gross margin of 75.5 percent and non-GAAP gross margin of 76.6 percent - Fully diluted GAAP EPS of $0.15 and fully diluted non-GAAP EPS of $0.21 AUSTIN, Texas , April 25, 2013 /PRNewswire/ -- National Instruments (Nasdaq: NATI) today announced Q1 revenue of $286 million , a new first quarter record and a 10 percent increase from Q1 2012.
Sign-up for National Instruments Reports Record First Quarter Revenue investment picks
2013/4/25
Seventh Consecutive Quarter of Year-Over-Year Growth CHELMSFORD, Mass.
Sign-up for Datawatch Announces Fiscal Second Quarter 2013 Financial Results investment picks
2013/4/25
Dyax Corp.
Sign-up for Dyax Corp. Announces First Quarter 2013 Financial Results investment picks
2013/4/25
REITERATES 2013 GUIDANCE PLEASANTON, Calif., April 25, 2013 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc., (Nasdaq:ZLTQ) a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced financial results for the first quarter 2013.
Sign-up for ZELTIQ Aesthetics Announces First Quarter 2013 Financial Results investment picks
2013/4/25
Walter Energy Inc. (NYSE: WLT) (TSX: WLT) , a leading, publicly traded "pure-play" producer of metallurgical coal for the global steel industry, today announced that its Board of Directors has declared a regular quarterly dividend of $0.125 per common share payable on June 7, 2013, to shareholders of record as of the close of business on May 10, 2013.
Sign-up for Walter Energy’s Board of Directors Declares Quarterly Dividend investment picks
2013/4/25
Phase 3 Trial of Niraparib in Breast Cancer to be Initiated in the Second Half of 2013 Phase 3 Trial of Niraparib in Ovarian Cancer on Track to Begin Enrolling Mid-2013 Top-Line Results of Rolapitant Phase 3 Program to be Announced in the Second Half of 2013 Fifth Dose Level Achieved in Phase 1/2 Clinical Trial of TSR-011 Net Cash Position Totaled Approximately $199 Million as of March 31, 2013 WALTHAM, Mass., April 25, 2013 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today reported financial results for the first quarter of 2013.
Sign-up for Tesaro Announces First-Quarter 2013 Operating Results investment picks
2013/4/25
Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for XELJANZ ® (tofacitinib citrate) for the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA). The CHMP is of the opinion that XELJANZ does not demonstrate a favorable risk:benefit profile at this time and recommended against marketing authorization.
Sign-up for Pfizer Receives CHMP Negative Opinion Regarding Marketing Authorization In Europe For Rheumatoid Arthritis Treatment XELJANZ® (tofacitinib citrate) investment picks
2013/4/25
Town Sports International Holdings, Inc. (“TSI” or the “Company”) (NASDAQ: CLUB) , a leading owner and operator of health clubs located primarily in major cities from Washington, DC north through New England, operating under the brand names “New York Sports Clubs,” “Boston Sports Clubs,” “Washington Sports Clubs” and “Philadelphia Sports Clubs,” announced its results for the first quarter ended March 31, 2013.
Sign-up for Town Sports International Holdings, Inc. Announces First Quarter 2013 Financial Results investment picks
2013/4/25
--Equity and bond assets increase $2.6 billion during Q1 2013 to a record $98 billion --Board declares $0.24 per share quarterly dividend PITTSBURGH , April 25, 2013 /PRNewswire/ -- Federated Investors, Inc. (NYSE: FII) , one of the nation's largest investment managers, today reported earnings per diluted share (EPS) of $0.41 for the quarter ended March 31, 2013 , which was unchanged from the same quarter last year.
Sign-up for Federated Investors, Inc. Reports First Quarter 2013 Earnings investment picks
2013/4/25
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010911&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Announces Plan to Separate Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations investment picks
2013/4/25
ATHENS, Greece , April 25, 2013 /PRNewswire/ -- Box Ships Inc. (NYSE: TEU) (the "Company"), a global shipping company specializing in the seaborne transportation of containers, announced today its results for the quarter ended March 31, 2013 .
Sign-up for Box Ships Inc. Reports Quarter Ended March 31, 2013 Results And Declares Quarterly Dividend Of $0.12 Per Common Share investment picks
2013/4/25
http://media.marketwire.com/attachments/201005/597775_newlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010883&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Micrel Reports 2013 First Quarter Financial Results investment picks
2013/4/25
KANSAS CITY, Mo., April 25, 2013 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2013 first quarter that ended March 30, 2013, delivering strong levels of bookings, earnings and cash flow.
Sign-up for Cerner Reports First Quarter 2013 Results investment picks
2013/4/25
Company Delivers Strong Bottom Line Results; Redbox Increases Market Share Lead; Coin Expands in Canada with TD Canada Trust BELLEVUE, Wash.
Sign-up for Coinstar, Inc. Announces 2013 First Quarter Results investment picks
2013/4/25
Hittite Microwave Corporation (NASDAQ:HITT) today reported revenue for the first quarter ended March 31, 2013 of $67.7 million, an increase of 6.9% compared with $63.3 million for the first quarter of 2012, and a decrease of 1.2% compared with $68.5 million for the fourth quarter of 2012.
Sign-up for Hittite Microwave Corporation Reports Financial Results for the First Quarter of 2013 investment picks
2013/4/25
MILWAUKEE, April 25, 2013 (GLOBE NEWSWIRE) -- STRATTEC SECURITY CORPORATION (Nasdaq:STRT) today reported operating results for the fiscal third quarter ended March 31, 2013.
Sign-up for STRATTEC SECURITY CORPORATION Reports Fiscal 2013 Third Quarter Results investment picks
2013/4/25
TROY, N.C. , April 25, 2013 /PRNewswire/ -- First Bancorp (NASDAQ: FBNC) , the parent company of First Bank, announced today net income available to common shareholders of $2.9 million , or $0.14 per diluted common share, for the three months ended March 31, 2013 , compared to a net loss available to common shareholders of $5.9 million , or ($0.35) per diluted common share, recorded in the first quarter of 2012.
Sign-up for First Bancorp Reports First Quarter Results investment picks
2013/4/25
CHICOPEE, Mass., April 25, 2013 (GLOBE NEWSWIRE) -- Chicopee Bancorp, Inc. (the "Company") (Nasdaq:CBNK) , the holding company for Chicopee Savings Bank (the "Bank"), announced the unaudited results of operations for the three months ended March 31, 2013.
Sign-up for Chicopee Bancorp, Inc. Reports First Quarter Results and Announces Quarterly Cash Dividend of $0.05 Per Share investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: National Instruments Declares Quarterly Dividend to Chicopee Bancorp, Inc. Reports First Quarter Results and Announces Quarterly Cash Dividend of $0.05 Per Share
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity